[Hyperfractionated irradiation of esophageal cancer. Initial results of a pilot study].
A group of 21 patients with esophagus carcinomas was submitted to hyperfractionated irradiation with a total reference dose of 65 Gy, applied in 50 fractions over five weeks. Generally, the irradiation was well tolerated. About 49% of the patients are alive one year later.
Schnabel
K
K
Abteilung für Strahlentherapie, Radiologische Universitätsklinik Homburg/Saar.
Berberich
W
W
Niewald
M
M
Tkocz
H J
HJ
Scharding
B
B
D000230:Adenocarcinoma / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D004938:Esophageal Neoplasms / Q000532:radiotherapy*; D006801:Humans; D008875:Middle Aged; D010865:Pilot Projects; D011379:Prognosis; D011879:Radiotherapy Dosage
Hyperfraktionierte Bestrahlung von Osophaguskarzinomen. Erste Ergebnisse einer Pilotstudie.